http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
New Crypto Pepeto Binance Listing Update Follow Shiba Inu Success While Cardano Price Prediction Point To $9
-
HTX Opens Trading for PROS (Pharos Network)
-
EU approves Arrowhead's plozasiran for rare triglyceride disorder
-
Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
-
BeritaWire Launches Affordable Press Release Distribution Services Across Indonesia
-
Aelis Farma discloses share buyback program details
-
Aelis Farma: Availability of the Description of the Share Buyback Program
-
YourSecret Introduces Match by Mindset, Not Profiles
-
Hyundai and Hyundai Hope on Wheels Invest $500,000 in Rady Children's Health Orange County to Champion Pediatric Health and Lifesaving Research
-
Walmart expands pharmacy support for Medicare GLP-1 coverage
-
HII wins $418M Navy contract for shipboard elevator maintenance
-
Walmart and Sam’s Club Expand Support for Medicare Customers as New Weight Management Coverage Launches
-
HII Awarded $418 Million Contract to Continue Supporting Fleet Operational Readiness for the U.S. Navy
-
CBD of Denver Announces Updated Corporate Website Reflecting Strategic Pivot into Artificial Intelligence
-
RS is again named one of North America's most inspiring workplaces
-
Interactive Brokers adds ChatGPT and Grok to its AI trading tools
-
Interactive Brokers Expands AI Integration Capabilities – Adding ChatGPT and Grok to Its Growing Suite of Agentic Trading Tools
-
FatPipe Awarded 2026 Visionary Spotlight Award for Total Security 360 by ChannelVision Magazine
-
Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary
-
AMTD Group and AMTD IDEA Reaffirm Long-Term Commitment to TGE with a Two-Year Voluntary Lock-Up
-
AMTD group discloses share repurchase totals, plans to expand buybacks
-
AMTD Announces Progress on Share Repurchase Programs and Communicates Intent to Accelerate Buybacks
-
Nextlink expands Aviat Networks deal for rural broadband buildout
-
Nextlink Internet expands Agreement with Aviat Networks to Power BEAD-Funded Rural Broadband Buildout
-
EchoStar to change Nasdaq ticker from SATS to ECHO on June 24
-
Schneider Electric Advances Open, Software-Defined Automation at Automate 2026
-
Church's Texas Chicken® Brings Back Smokehouse Chicken with NEW Lemon Pepper Flavor
-
Genprex receives Canadian patent notice for Reqorsa combo therapy
-
Lexar Delivers Prime Day Savings of up to 50% on Popular Memory Cards, Flash Drives, and Portable SSDs
-
EchoStar Changing Stocker Ticker SATS to ECHO, Marking the Company's Next Era on Earth and in Space
-
CSX Corp. Announces Date for Second Quarter Earnings Release and Earnings Call
-
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Canc
-
VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
-
EchoStar Changing Stocker Ticker SATS to ECHO, Marking the Company's Next Era on Earth and in Space
-
FDA backs Entera Bio's Phase 3 trial plan for oral osteoporosis drug
-
Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis
-
MAX Power Mining names Chad Levesque president and board director
-
FDA grants breakthrough therapy status to Praxis drug for rare epilepsy
-
Exelixis colorectal cancer trial misses one of two survival goals
-
Cardiovascular Logistics Appoints Meagan Strawhacker as Vice President of Clinical Recruiting
-
Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD
-
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of
-
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
-
Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
-
MAX Power Appoints Chad Levesque as President and New Board Director as Company Advances Toward Commercialization of Natural Hydrogen
-
Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer
-
FDA grants rolling review for Palvella's rapamycin NDA for rare condition
-
FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations
-
iCapital® and UMB Expand Blockchain-Enabled Network for Alternative Investments Through Distributed Ledger Technology Integration
-
American Resources' Affiliated Holding ReElement Technologies Provides Progress Update on Marion, Indiana Rare Earth and Critical Mineral Refining Campus
